TY - JOUR T1 - Amiodarone maintained sinus rhythm better than sotalol or placebo in atrial fibrillation, but adverse effects were more frequent JF - Evidence Based Medicine JO - Evid Based Med SP - 42 LP - 42 DO - 10.1136/ebm.6.2.42 VL - 6 IS - 2 A2 - , Y1 - 2001/03/01 UR - http://ebm.bmj.com/content/6/2/42.abstract N2 - (2000) Heart 84, 251. Kochiadakis GE, Igoumenidis NE, Marketou ME, et al.. Low dose amiodarone and sotalol in the treatment of recurrent, symptomatic atrial fibrillation: a comparative, placebo controlled study.. Sep;. :. –7.OpenUrlAbstract/FREE Full Text
 
 QUESTION: In patients with recurrent atrial fibrillation (AF), are amiodarone and sotalol safe and effective for maintaining sinus rhythm? Randomised (allocation not concealed*), blinded (patients),* placebo controlled trial with mean follow up of 22 months. A tertiary cardiac referral centre in a university hospital in Greece. 186 patients (mean age 63 y, 52% men) who had symptomatic chronic or paroxysmal AF confirmed by electrocardiography. Inclusion criteria were >18 years of age and successful chemical or electrical cadioversion to sinus rhythm. Exclusion criteria were recent acute myocardial infarction, cardiogenic shock, transient AF related to an ongoing disease or condition, unstable hepatic or renal function, ejection fraction <40%, hyperthyroidism, life expectancy <1 year, or previous exposure to study drugs. Follow up … ER -